NCT06243094

Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)

Survey on Antibiotic Therapy Practices for Ventilator-Associated Pneumonia in ICU Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,060 (estimated)
• Sponsor: French Society for Intensive Care · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The French Society of Intensive Care conducts a comprehensive assessment of current antibiotic therapy practices in critically ill patients suspected of Ventilator-Associated Pneumonia (VAP).

Detailed description

This prospective observational multicenter study will be conducted in intensive care units (ICU) across France and French-speaking regions. The primary objective of this study is to delineate the characteristics of antibiotic treatments administered for a first episode of suspected VAP. Secondary objectives include describing the outcomes of enrolled patients, assessing adherence to European guidelines regarding empirical antibiotic treatment, and identifying factors associated with mortality in patients with microbiologically confirmed VAP.

Conditions

• Ventilator Associated Pneumonia

Interventions

Type	Name	Description
DRUG	Antibiotic	All antibiotic therapy characteristics are monitored.

Timeline

• Start date: 2024-03-12
• Primary completion: 2025-03-12
• Completion: 2025-03-12
• First posted: 2024-02-06
• Last updated: 2024-03-15

Locations

1 site across 1 country: France